Trial Profile
Study on the symptom control of gastric acid suppressive drugs in reflux esophagitis patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Dec 2019
Price :
$35
*
At a glance
- Drugs Esomeprazole (Primary) ; Vonoprazan (Primary)
- Indications Reflux oesophagitis
- Focus Therapeutic Use
- 13 Dec 2019 Status changed from recruiting to completed.
- 07 Mar 2018 Status changed from not yet recruiting to recruiting.
- 08 Sep 2017 New trial record